Published :
Tables : 61
Figures : 51
Category : Healthcare
No. of Pages : 225
Report Code : HC-U3399
Electroencephalography (EEG) Devices Market is estimated to value over USD 1.9 billion by 2027 end with a CAGR of over 8.3% during the forecast period 2020 to 2027. Rising incidences of neurological diseases like epilepsy, Alzheimer’s, dementia, Parkinson’s diseases, multiple sclerosis is the primary reason for the growth of the market. As per the data provided by the Alzheimer’s Association, over 5.6 million people from the Unites States were diagnosed with Alzheimer’s diseases in 2018 and it is projected that over half the geriatric population by 2050 will be diagnosed with dementia. Furthermore, as per the data provided by the ALS Association, over 4,800 people from the Unites States are identified with Amyotrophic Lateral Sclerosis every year and it is predicted to double this number over the upcoming years. Growing geriatric population has resulted in the growth of research and development activities in the neuroscience sector. The strategic collaborations between Denali Therapeutics and Takeda have emphasized on developing drugs for diseases like Parkinson’s, Alzheimer’s and Pfizer’s partnership with Biogen for developing schizophrenia drugs shall boost the growth of the market. Additionally, according to the projections provided by the National Vital Statistics with compilation by the CDC, it is estimated that a average of over 180 years of potential life has been lost for people under the age of 75 years in the Unites States. Such a high prevalence rate shall bolster the electroencephalography devices market growth. Moreover, as per the Alzheimer’s Disease International, the South East Asia is predicted to experience over 220% rise in the number of Alzheimer’s case and the data from the same source project that the number of patients suffering with Alzheimer’s disease shall reach over 104 million by 2050. Electroencephalography (EEG) Devices Market Segmentation: By Product • 32-Channel EEG • 25-Channel EEG • 8-Channel EEG • 40-Channel EEG • 21-Channel EEG • Multichannel EEG By Type • Portable Devices • Standalone Devices By End Users • Hospitals • Diagnostic Centers • Others By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa The market is classified into product, type, end user and region. The product segment is categorised into 25-channel EEG, 32-channel EEG, 40-channel EEG, 21-channel EEG, 8-channel EEG and multichannel. The 32-channel EEG segment is predicted to hold the largest electroencephalography devices market share owing to technological advancements along with high acceptance of this device by healthcare personnel across the world. The type segment is diversified into portable devices and standalone devices. The standalone devices segment dominated the market owing to their increased adoption and a wide range of applications, especially in critical care. The portable EEG devices segment is anticipated to grow at a substantial rate during the forecasted time frame. Regional Analysis: The North America region is anticipated to dominate the market owing to growing occurrence of different neurodegenerative and sleep disorders, favourable insurance policies, strong presence of major market players in the region. Furthermore, organization like the National Institute of Neurological Disorders and Stroke providing research and development funds for neurological disorders shall bolster the growth of the market in the region. Competitive Landscape: Some of the major market players are Natus Medical Inc., Electrical Geodesics Inc., Medtronic, NeuroWave Systems Inc., Compumedics Ltd., Noraxon U.S.A., Inc., Cadwell Laboratories Inc., Nihon Kohden America Inc, Elekta AB, BrainScope. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global electroencephalography devices market by product, by type, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Rising incidences of neurological diseases like epilepsy, Alzheimer’s, dementia, Parkinson’s diseases, multiple sclerosis is the primary reason for the growth of the market. As per the data provided by the Alzheimer’s Association, over 5.6 million people from the Unites States were diagnosed with Alzheimer’s diseases in 2018 and it is projected that over half the geriatric population by 2050 will be diagnosed with dementia. Furthermore, as per the data provided by the ALS Association, over 4,800 people from the Unites States are identified with Amyotrophic Lateral Sclerosis every year and it is predicted to double this number over the upcoming years. Growing geriatric population has resulted in the growth of research and development activities in the neuroscience sector. The strategic collaborations between Denali Therapeutics and Takeda have emphasized on developing drugs for diseases like Parkinson’s, Alzheimer’s and Pfizer’s partnership with Biogen for developing schizophrenia drugs shall boost the growth of the market. Additionally, according to the projections provided by the National Vital Statistics with compilation by the CDC, it is estimated that a average of over 180 years of potential life has been lost for people under the age of 75 years in the Unites States. Such a high prevalence rate shall bolster the electroencephalography devices market growth. Moreover, as per the Alzheimer’s Disease International, the South East Asia is predicted to experience over 220% rise in the number of Alzheimer’s case and the data from the same source project that the number of patients suffering with Alzheimer’s disease shall reach over 104 million by 2050.
Electroencephalography (EEG) Devices Market Segmentation:
By Product • 32-Channel EEG • 25-Channel EEG • 8-Channel EEG • 40-Channel EEG • 21-Channel EEG • Multichannel EEG By Type • Portable Devices • Standalone Devices By End Users • Hospitals • Diagnostic Centers • Others By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa
The market is classified into product, type, end user and region. The product segment is categorised into 25-channel EEG, 32-channel EEG, 40-channel EEG, 21-channel EEG, 8-channel EEG and multichannel. The 32-channel EEG segment is predicted to hold the largest electroencephalography devices market share owing to technological advancements along with high acceptance of this device by healthcare personnel across the world. The type segment is diversified into portable devices and standalone devices. The standalone devices segment dominated the market owing to their increased adoption and a wide range of applications, especially in critical care. The portable EEG devices segment is anticipated to grow at a substantial rate during the forecasted time frame.
Regional Analysis:
The North America region is anticipated to dominate the market owing to growing occurrence of different neurodegenerative and sleep disorders, favourable insurance policies, strong presence of major market players in the region. Furthermore, organization like the National Institute of Neurological Disorders and Stroke providing research and development funds for neurological disorders shall bolster the growth of the market in the region.
Competitive Landscape:
Some of the major market players are Natus Medical Inc., Electrical Geodesics Inc., Medtronic, NeuroWave Systems Inc., Compumedics Ltd., Noraxon U.S.A., Inc., Cadwell Laboratories Inc., Nihon Kohden America Inc, Elekta AB, BrainScope.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global electroencephalography devices market by product, by type, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Electroencephalography Devices Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1. 32-Channel EEG 7.2. 25-Channel EEG 7.3. 8-Channle EEG 7.4. 40-Channle EEG 7.5. 21-Channel EEG 7.6. Multichannel EEG 8. Electroencephalography Devices Market, By Type Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Portable Devices 8.2 Standalone Devices 9. Electroencephalography Devices Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 9.1 Hospitals 9.2 Diagnostic Centers 9.3 Others 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 10.2.1. U.S. 10.2.2. Canada 10.2.3. Mexico 10.2.4 Rest of North America 10.3 Market Size (USD Mn) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Uruguay 11.3.3 Argentina 11.3.4. Rest of Latin America 11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5 Switzerland 12.2.6. Spain 12.2.7. Russia 12.2.8. Poland 12.2.9. Rest of Western Europe 12.3 Market Size (US$ Mn) Forecast for North America 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 Japan 13.2.2 China 13.2.3 Singapore 13.2.4 Korea 13.2.5 India 13.2.6 Australia and New Zealand 13.2.7 ASEAN 13.2.8 Rest of Asia Pacific 13.3 Market Size (US$ Mn) Forecast for North America 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1 Introduction 14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 14.2.1 UAE 14.2.2 South Africa 14.2.3 Egypt 14.2.4 Saudi Arabia 14.2.5 Rest of MEA 14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 15.1 Natus Medical Inc. 15.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2 Electrical Geodesics Inc. 15.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3 Medtronic 15.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4 NeuroWave Systems Inc. 15.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Compumedics Ltd. 15.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 Noraxon U.S.A. Inc. 15.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7 Cadwell Laboratories Inc. 15.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8 Nihon Kohden America Inc. 15.8.1. Company Overview (HQ, Business Segments, Employee Strength) 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9 BrainScope 15.9.1. Company Overview (HQ, Business Segments, Employee Strength) 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10 Elekta AB 15.10.1. Company Overview (HQ, Business Segments, Employee Strength) 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 16 Impact of COVID-19 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17 Competitive Intelligence and Competitive Matrix 17.1 Competitive Intelligence 17.2 Competitive Matrix 18. Major Deals and Strategic Alliances Analysis 18.1 Joint ventures 18.2 Mergers and acquisitions 18.3 Licensing and partnerships 18.4 Technology Collaborations 18.5 Strategic Divestments 18.6 Market Entry Strategies 19. Relevant Case Studies and Latest News Updates 20. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics